Ketamine Use for Cancer and Chronic Pain Management
Ketamine, an N-methyl-D-aspartate receptor antagonist, is widely known as a dissociative anesthetic and phencyclidine derivative. Due to an undesirable adverse event profile when used as an anesthetic it had widely fallen out of human use in favor of more modern agents. However, it has recently been...
Saved in:
Main Authors: | Clayton Culp (Author), Hee Kee Kim (Author), Salahadin Abdi (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rolipram, a Selective Phosphodiesterase 4 Inhibitor, Ameliorates Mechanical Hyperalgesia in a Rat Model of Chemotherapy-Induced Neuropathic Pain through Inhibition of Inflammatory Cytokines in the Dorsal Root Ganglion
by: Hee Kee Kim, et al.
Published: (2017) -
Analgesic effect of intranasal ketamine in the treatment of chronic cancer pain
by: Secundino González Pardo, et al.
Published: (2022) -
Topical (S)-ketamine for pain management of postherpetic neuralgia
by: Guilherme Antonio Moreira de Barros, et al.
Published: (2012) -
Combining ketamine with astrocytic inhibitor as a potential analgesic strategy for neuropathic pain. ketamine, astrocytic inhibitor and pain
by: Mei Xiao-Peng, et al.
Published: (2010) -
Ketamine for sedation in acutely painful procedures in Kenya: findings after implementation of the Every Second Matters-Ketamine package
by: Moytrayee Guha, MPH, et al.
Published: (2019)